BMP-12 Treatment Enhances Tendon-Like Tissue Formation from Stem Cells
Author Information
Author(s): Lee Jonathan Y., Zhou Zuping, Taub Peter J., Ramcharan Melissa, Li Yonghui, Akinbiyi Takintope, Maharam Edward R., Leong Daniel J., Laudier Damien M., Ruike Takuya, Torina Phillip J., Zaidi Mone, Majeska Robert J., Schaffler Mitchell B., Flatow Evan L., Sun Hui B.
Primary Institution: Mount Sinai School of Medicine, New York, New York, United States of America
Hypothesis
Can BMP-12 induce differentiation of mesenchymal stem cells into tenocyte-like cells and sustain this phenotype in vivo?
Conclusion
BMP-12 treatment effectively induces differentiation of mesenchymal stem cells into tenocyte-like cells, leading to improved tendon-like tissue formation in vivo.
Supporting Evidence
- BMP-12 treatment increased expression of tendon markers Scx and Tnmd in stem cells.
- Over 80% of colonies from treated stem cells expressed tenocyte markers after BMP-12 treatment.
- Implants of BMP-12 treated stem cells showed robust tendon-like tissue formation in vivo.
Takeaway
Researchers found that a special protein called BMP-12 can help stem cells turn into tendon cells, which can then help repair tendons better.
Methodology
The study involved treating rat bone marrow-derived mesenchymal stem cells with BMP-12 and assessing their differentiation and tissue formation in vitro and in vivo.
Limitations
The long-term stability of the tenocyte phenotype in vivo remains to be fully evaluated.
Participant Demographics
Sprague-Dawley female rats, 5-6 months old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website